Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: EyeDrMike who wrote (3125)	12/9/1997 1:20:00 PM
From: BigKNY3	Respond to of 23519

Eye: << Just look at the PFE share price, it seems to have hit the ceiling, Hit 80 recently, and immediately dropped back down. Lack of buyers here. <possible short?>>> Eye: After reaching its high of 80 last Thursday, PFE had an expected bout of profit-taking. PFE is back up strong heading to 77. Trust me this is one stock you don't want to short. Within a month, PFE should be receiving a FDA approval on a new quinolone antibiotic called Trovan. BigKNY3